Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses In Pivotal Study

This week, companies like Mylan, Allergan and Teva reported earnings results. The spotlight also remained on Roche which saw its immuno-oncology drug fail in a pivotal study.